Contact
searchSearch
HMP Global

Respiratory Syncytial Virus Topic Center

Featured Article

News
Adjuvanted Vaccines May Increase RSV-Neutralizing Antibody Levels in Immunocompromised Individuals, Study Finds
01/10/2025
Older adults with weakened immune systems, such as organ transplant recipients on immunosuppressive medications, respond less robustly to respiratory syncytial virus (RSV) vaccines than their peers with normal immune function.
Older adults with weakened immune systems, such as organ transplant recipients on immunosuppressive medications, respond less robustly to respiratory syncytial virus (RSV) vaccines than their peers with normal immune function.
Older adults with weakened...
01/10/2025
Pharmacy Learning Network
News
RSVpreF Vaccine Demonstrates Strong Efficacy and Safety Against RSV Infections
12/17/2024
Revaccination with the bivalent respiratory syncytial virus (RSV) prefusion F (RSV-preF) vaccination 12 months after initial vaccination was well tolerated and immunogenic in healthy adults.
Revaccination with the bivalent respiratory syncytial virus (RSV) prefusion F (RSV-preF) vaccination 12 months after initial vaccination was well tolerated and immunogenic in healthy adults.
Revaccination with the bivalent...
12/17/2024
Pharmacy Learning Network
News
Respiratory Syncytial Virus Subgroups A and B Contribute Equally to the Global RSV Burden, Study Finds
12/06/2024
Respiratory syncytial virus (RSV) A and B contribute to the global RSV burden, and both subgroups cause severe disease, with no available evidence suggesting differences in clinical severity between the subgroups, according to a study...
Respiratory syncytial virus (RSV) A and B contribute to the global RSV burden, and both subgroups cause severe disease, with no available evidence suggesting differences in clinical severity between the subgroups, according to a study...
Respiratory syncytial virus...
12/06/2024
Pharmacy Learning Network
News
Community Pharmacies Play a Pivotal Role in Boosting RSV Vaccine Uptake in Older Adults
11/22/2024
Despite its prevalence and the availability of a respiratory syncytial virus (RSV) vaccine approved in May 2023, awareness of RSV and its vaccine remains limited, and community pharmacies have the potential play a pivotal role in addressing...
Despite its prevalence and the availability of a respiratory syncytial virus (RSV) vaccine approved in May 2023, awareness of RSV and its vaccine remains limited, and community pharmacies have the potential play a pivotal role in addressing...
Despite its prevalence and the...
11/22/2024
Pharmacy Learning Network
News
Tracking RSV Evolution and Treatment Resistance Through Genomic Surveillance
11/08/2024
The Minnesota Department of Health recently expanded its viral genomic surveillance program expanded to include human respiratory syncytial virus to track genetic diversity and investigate viral circulation dynamics using whole-genome...
The Minnesota Department of Health recently expanded its viral genomic surveillance program expanded to include human respiratory syncytial virus to track genetic diversity and investigate viral circulation dynamics using whole-genome...
The Minnesota Department of...
11/08/2024
Pharmacy Learning Network
News
Study Sheds Light on RSV Structural Protein Organization, Paving the Way for Vaccine Improvements
10/18/2024
A new study published in Nature Communications has provided crucial insights into the structure and organization of respiratory syncytial virus (RSV).
A new study published in Nature Communications has provided crucial insights into the structure and organization of respiratory syncytial virus (RSV).
A new study published in Nature...
10/18/2024
Pharmacy Learning Network
News
RSV Identified as Significant Contributor to COPD Exacerbations
10/04/2024
Respiratory syncytial virus (RSV) is linked to approximately 8.7% of chronic obstructive pulmonary disease (COPD) exacerbations in European cohorts, with RSV-related exacerbations showing a tendency to resolve more quickly than those caused...
Respiratory syncytial virus (RSV) is linked to approximately 8.7% of chronic obstructive pulmonary disease (COPD) exacerbations in European cohorts, with RSV-related exacerbations showing a tendency to resolve more quickly than those caused...
Respiratory syncytial virus...
10/04/2024
Pharmacy Learning Network
News
Comprehensive Review Reveals Substantial Burden of Respiratory Syncytial Virus in Adults Worldwide
09/10/2024
Respiratory syncytial virus (RSV) poses a significant health risk, particularly for older adults and those with underlying health conditions, according to a study published in The Journal of Infectious Diseases.
Respiratory syncytial virus (RSV) poses a significant health risk, particularly for older adults and those with underlying health conditions, according to a study published in The Journal of Infectious Diseases.
Respiratory syncytial virus...
09/10/2024
Pharmacy Learning Network
News
Approach Allows for Rapid Detection of 8 Respiratory Viruses
08/26/2024
A combination of bioinformatics analysis and nanomaterial optimization improves the sensitivity, specificity, and detection rate of viral diagnosis of respiratory viruses, according to a study published in Frontiers and Biotechnology.
A combination of bioinformatics analysis and nanomaterial optimization improves the sensitivity, specificity, and detection rate of viral diagnosis of respiratory viruses, according to a study published in Frontiers and Biotechnology.
A combination of bioinformatics...
08/26/2024
Pharmacy Learning Network
News
CDC Recommends RSV Vaccination for Older Adults Who Have Not Received It
08/07/2024
Studies are currently investigating how long protection lasts after receiving the respiratory syncytial virus (RSV) vaccine.
Studies are currently investigating how long protection lasts after receiving the respiratory syncytial virus (RSV) vaccine.
Studies are currently...
08/07/2024
Pharmacy Learning Network
News
Officials Will Continue to Assess Guillain-Barré Syndrome Risk After RSV Vaccine
06/12/2024
Consistent with prelicensure clinical trials, nearly a year of respiratory syncytial virus (RSV) vaccine use in US older adults showed higher-than-expected rates of Guillain-Barré syndrome after RSV vaccination compared with after COVID-19...
Consistent with prelicensure clinical trials, nearly a year of respiratory syncytial virus (RSV) vaccine use in US older adults showed higher-than-expected rates of Guillain-Barré syndrome after RSV vaccination compared with after COVID-19...
Consistent with prelicensure...
06/12/2024
Pharmacy Learning Network

Newsfeed

News
Adjuvanted Vaccines May Increase RSV-Neutralizing Antibody Levels in Immunocompromised Individuals, Study Finds
01/10/2025
Older adults with weakened immune systems, such as organ transplant recipients on immunosuppressive medications, respond less robustly to respiratory syncytial virus (RSV) vaccines than their peers with normal immune function.
Older adults with weakened immune systems, such as organ transplant recipients on immunosuppressive medications, respond less robustly to respiratory syncytial virus (RSV) vaccines than their peers with normal immune function.
Older adults with weakened...
01/10/2025
Pharmacy Learning Network
News
RSVpreF Vaccine Demonstrates Strong Efficacy and Safety Against RSV Infections
12/17/2024
Revaccination with the bivalent respiratory syncytial virus (RSV) prefusion F (RSV-preF) vaccination 12 months after initial vaccination was well tolerated and immunogenic in healthy adults.
Revaccination with the bivalent respiratory syncytial virus (RSV) prefusion F (RSV-preF) vaccination 12 months after initial vaccination was well tolerated and immunogenic in healthy adults.
Revaccination with the bivalent...
12/17/2024
Pharmacy Learning Network
News
Respiratory Syncytial Virus Subgroups A and B Contribute Equally to the Global RSV Burden, Study Finds
12/06/2024
Respiratory syncytial virus (RSV) A and B contribute to the global RSV burden, and both subgroups cause severe disease, with no available evidence suggesting differences in clinical severity between the subgroups, according to a study...
Respiratory syncytial virus (RSV) A and B contribute to the global RSV burden, and both subgroups cause severe disease, with no available evidence suggesting differences in clinical severity between the subgroups, according to a study...
Respiratory syncytial virus...
12/06/2024
Pharmacy Learning Network
News
Community Pharmacies Play a Pivotal Role in Boosting RSV Vaccine Uptake in Older Adults
11/22/2024
Despite its prevalence and the availability of a respiratory syncytial virus (RSV) vaccine approved in May 2023, awareness of RSV and its vaccine remains limited, and community pharmacies have the potential play a pivotal role in addressing...
Despite its prevalence and the availability of a respiratory syncytial virus (RSV) vaccine approved in May 2023, awareness of RSV and its vaccine remains limited, and community pharmacies have the potential play a pivotal role in addressing...
Despite its prevalence and the...
11/22/2024
Pharmacy Learning Network
News
Tracking RSV Evolution and Treatment Resistance Through Genomic Surveillance
11/08/2024
The Minnesota Department of Health recently expanded its viral genomic surveillance program expanded to include human respiratory syncytial virus to track genetic diversity and investigate viral circulation dynamics using whole-genome...
The Minnesota Department of Health recently expanded its viral genomic surveillance program expanded to include human respiratory syncytial virus to track genetic diversity and investigate viral circulation dynamics using whole-genome...
The Minnesota Department of...
11/08/2024
Pharmacy Learning Network
News
Study Sheds Light on RSV Structural Protein Organization, Paving the Way for Vaccine Improvements
10/18/2024
A new study published in Nature Communications has provided crucial insights into the structure and organization of respiratory syncytial virus (RSV).
A new study published in Nature Communications has provided crucial insights into the structure and organization of respiratory syncytial virus (RSV).
A new study published in Nature...
10/18/2024
Pharmacy Learning Network
News
RSV Identified as Significant Contributor to COPD Exacerbations
10/04/2024
Respiratory syncytial virus (RSV) is linked to approximately 8.7% of chronic obstructive pulmonary disease (COPD) exacerbations in European cohorts, with RSV-related exacerbations showing a tendency to resolve more quickly than those caused...
Respiratory syncytial virus (RSV) is linked to approximately 8.7% of chronic obstructive pulmonary disease (COPD) exacerbations in European cohorts, with RSV-related exacerbations showing a tendency to resolve more quickly than those caused...
Respiratory syncytial virus...
10/04/2024
Pharmacy Learning Network
News
Comprehensive Review Reveals Substantial Burden of Respiratory Syncytial Virus in Adults Worldwide
09/10/2024
Respiratory syncytial virus (RSV) poses a significant health risk, particularly for older adults and those with underlying health conditions, according to a study published in The Journal of Infectious Diseases.
Respiratory syncytial virus (RSV) poses a significant health risk, particularly for older adults and those with underlying health conditions, according to a study published in The Journal of Infectious Diseases.
Respiratory syncytial virus...
09/10/2024
Pharmacy Learning Network
News
Approach Allows for Rapid Detection of 8 Respiratory Viruses
08/26/2024
A combination of bioinformatics analysis and nanomaterial optimization improves the sensitivity, specificity, and detection rate of viral diagnosis of respiratory viruses, according to a study published in Frontiers and Biotechnology.
A combination of bioinformatics analysis and nanomaterial optimization improves the sensitivity, specificity, and detection rate of viral diagnosis of respiratory viruses, according to a study published in Frontiers and Biotechnology.
A combination of bioinformatics...
08/26/2024
Pharmacy Learning Network
News
CDC Recommends RSV Vaccination for Older Adults Who Have Not Received It
08/07/2024
Studies are currently investigating how long protection lasts after receiving the respiratory syncytial virus (RSV) vaccine.
Studies are currently investigating how long protection lasts after receiving the respiratory syncytial virus (RSV) vaccine.
Studies are currently...
08/07/2024
Pharmacy Learning Network
News
Antidepressants Recalled Due to Impurity Contamination
01/15/2025
Rising Pharma Holding, Inc. has issued a voluntary nationwide recall of multiple lots of duloxetine delayed-release (DR) Capsules in various dosages.
Rising Pharma Holding, Inc. has issued a voluntary nationwide recall of multiple lots of duloxetine delayed-release (DR) Capsules in various dosages.
Rising Pharma Holding, Inc. has...
01/15/2025
Pharmacy Learning Network
News
Seizure Medication Recalled Over Foreign Tablet Contamination
01/15/2025
Amneal Pharmaceuticals LLC has initiated a voluntary recall of clobazam tablets, 10 mg, packaged in 30-tablet cartons (NDC 60687-423-21) distributed by American Health Packaging.
Amneal Pharmaceuticals LLC has initiated a voluntary recall of clobazam tablets, 10 mg, packaged in 30-tablet cartons (NDC 60687-423-21) distributed by American Health Packaging.
Amneal Pharmaceuticals LLC has...
01/15/2025
Pharmacy Learning Network
News
Benzodiazepine Tablets Recalled Over Label Strength Discrepancy
01/15/2025
The FDA has announced a nationwide recall of clonazepam orally disintegrating tablets in various strengths distributed by PAR Pharmaceutical and manufactured by Endo USA, Inc.
The FDA has announced a nationwide recall of clonazepam orally disintegrating tablets in various strengths distributed by PAR Pharmaceutical and manufactured by Endo USA, Inc.
The FDA has announced a...
01/15/2025
Pharmacy Learning Network
News
Adjuvanted Vaccines May Increase RSV-Neutralizing Antibody Levels in Immunocompromised Individuals, Study Finds
01/10/2025
Older adults with weakened immune systems, such as organ transplant recipients on immunosuppressive medications, respond less robustly to respiratory syncytial virus (RSV) vaccines than their peers with normal immune function.
Older adults with weakened immune systems, such as organ transplant recipients on immunosuppressive medications, respond less robustly to respiratory syncytial virus (RSV) vaccines than their peers with normal immune function.
Older adults with weakened...
01/10/2025
Pharmacy Learning Network
News
Hypothyroidism Medication Recalled Over Impurity Concerns
01/09/2025
Lupin Pharmaceuticals has issued a Class II recall of Levothyroxine sodium tablets, 75 mcg, due to impurity and degradation issues identified during stability testing, potentially affecting medication safety and efficacy
Lupin Pharmaceuticals has issued a Class II recall of Levothyroxine sodium tablets, 75 mcg, due to impurity and degradation issues identified during stability testing, potentially affecting medication safety and efficacy
Lupin Pharmaceuticals has issued...
01/09/2025
Pharmacy Learning Network
News
UTI Medication Recalled Due to Quality Defects
01/09/2025
AvKARE has issued a nationwide Class II recall of Nitrofurantoin capsules, USP, 100 mg, due to failed dissolution specifications, potentially impacting treatment effectiveness for urinary tract infections.
AvKARE has issued a nationwide Class II recall of Nitrofurantoin capsules, USP, 100 mg, due to failed dissolution specifications, potentially impacting treatment effectiveness for urinary tract infections.
AvKARE has issued a nationwide...
01/09/2025
Pharmacy Learning Network
News
Dietary Supplements Recalled Due to Undeclared Pharmaceutical Ingredients
01/08/2025
The FDA has issued a Class I recall of FORCE FOREVER 400mg Tablets, a dietary supplement for joint and bone health, due to undeclared pharmaceutical ingredients that pose serious health risks.
The FDA has issued a Class I recall of FORCE FOREVER 400mg Tablets, a dietary supplement for joint and bone health, due to undeclared pharmaceutical ingredients that pose serious health risks.
The FDA has issued a Class I...
01/08/2025
Pharmacy Learning Network
News
Antidepressant Capsules Recalled Over Impurity
12/18/2024
Amerisource Health Services LLC is recalling tens of thousands of bottles of duloxetine delayed-release capsules because of an N-nitroso duloxetine impurity.
Amerisource Health Services LLC is recalling tens of thousands of bottles of duloxetine delayed-release capsules because of an N-nitroso duloxetine impurity.
Amerisource Health Services LLC...
12/18/2024
Pharmacy Learning Network
News
Vials Recalled for Glass Delamination Concerns
12/18/2024
American Regent Inc is recalling 10 lots of Venofer (iron sucrose) injection because of the potential for glass delamination of the vials.
American Regent Inc is recalling 10 lots of Venofer (iron sucrose) injection because of the potential for glass delamination of the vials.
American Regent Inc is recalling...
12/18/2024
Pharmacy Learning Network
News
Male Performance Supplements Recalled for Hidden Drug Ingredients
12/18/2024
A Class I recall has been issued for dietary supplements marketed for male performance and energy by Boulla LLC and VitalityVita.
A Class I recall has been issued for dietary supplements marketed for male performance and energy by Boulla LLC and VitalityVita.
A Class I recall has been issued...
12/18/2024
Pharmacy Learning Network

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use